BBAdmin

/BBAdmin

About BBAdmin

This author has not yet filled in any details.
So far BBAdmin has created 41 blog entries.

Medicenna Announces Closing of Public Offering of $6,900,000

By | October 17th, 2019|Bloom Burton, Financing, News|

Medicenna Announces Closing of Public Offering of $6,900,000 Original press [...]

Poul Sorensen Receives the 2019 Bloom Burton Award

By | September 30th, 2019|Uncategorized|

Poul Sorensen Receives the 2019 Bloom Burton Award September 30, [...]

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

By | September 9th, 2019|Bloom Burton, Financing, News|

BELLUS Health Closes US$70 Million Public Offering of Common Shares [...]

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

By | August 27th, 2019|Bloom Burton, Financing, News|

ESSA PHARMA COMPLETES PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT FOR [...]

Antibe Announces Closing of Public Offering

By | August 13th, 2019|Bloom Burton, Financing, News|

Antibe Announces Closing of Public Offering Original press release here [...]

Resverlogix Announces Closing of $15 Million Offering

By | June 7th, 2019|Financing, News|

Resverlogix Announces Closing of $15 Million Offering NOT FOR DISTRIBUTION [...]

HLS Therapeutics Announces Closing of $50 Million Bought Deal Offering

By | June 6th, 2019|Financing, News|

HLS Therapeutics Announces Closing of $50 Million Bought Deal Offering [...]

Greenbrook TMS Completes CAD $30 Million Bought Deal Public Offering and Concurrent Private Placement

By | May 17th, 2019|Financing, News|

Greenbrook TMS Completes CAD $30 Million Bought Deal Public Offering [...]

Three Finalists Announced for the 2019 Bloom Burton Award

By | May 7th, 2019|Bloom Burton, News|

Three Finalists Announced for the 2019 Bloom Burton Award Award [...]

Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease Portfolio

By | February 25th, 2019|News|

Ipsen to Acquire Clementia Pharmaceuticals to Significantly Boost Rare Disease [...]